nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.128	0.2	CbGbCtD
Valproic Acid—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0652	0.102	CbGbCtD
Valproic Acid—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.062	0.0974	CbGbCtD
Valproic Acid—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0608	0.0955	CbGbCtD
Valproic Acid—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0404	0.0634	CbGbCtD
Valproic Acid—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0318	0.0499	CbGbCtD
Valproic Acid—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0306	0.048	CbGbCtD
Valproic Acid—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0255	0.04	CbGbCtD
Valproic Acid—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0223	0.035	CbGbCtD
Valproic Acid—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0213	0.0335	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0204	0.032	CbGbCtD
Valproic Acid—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0173	0.0271	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0146	0.0229	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0134	0.021	CbGbCtD
Valproic Acid—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0133	0.0209	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0129	0.0202	CbGbCtD
Valproic Acid—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0124	0.0195	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0116	0.0182	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00996	0.0156	CbGbCtD
Valproic Acid—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00913	0.0143	CbGbCtD
Valproic Acid—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0057	0.00894	CbGbCtD
Valproic Acid—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00522	0.00819	CbGbCtD
Valproic Acid—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00356	0.00559	CbGbCtD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00297	0.723	CbGdCrCtD
Valproic Acid—HDAC2—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00114	0.277	CbGdCrCtD
Valproic Acid—UGT1A8—tongue—peripheral nervous system neoplasm	0.000699	0.2	CbGeAlD
Valproic Acid—HDAC2—tongue—peripheral nervous system neoplasm	0.000293	0.084	CbGeAlD
Valproic Acid—ACADSB—trigeminal ganglion—peripheral nervous system neoplasm	0.000256	0.0735	CbGeAlD
Valproic Acid—ACADSB—parotid gland—peripheral nervous system neoplasm	0.000242	0.0693	CbGeAlD
Valproic Acid—ALDH5A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000226	0.0647	CbGeAlD
Valproic Acid—ALDH5A1—brainstem—peripheral nervous system neoplasm	0.0002	0.0573	CbGeAlD
Valproic Acid—ABAT—brainstem—peripheral nervous system neoplasm	0.000171	0.049	CbGeAlD
Valproic Acid—HDAC2—trigeminal ganglion—peripheral nervous system neoplasm	0.000145	0.0417	CbGeAlD
Valproic Acid—OGDH—cerebellum—peripheral nervous system neoplasm	0.000141	0.0404	CbGeAlD
Valproic Acid—HDAC2—brainstem—peripheral nervous system neoplasm	0.000129	0.0369	CbGeAlD
Valproic Acid—HDAC9—cerebellum—peripheral nervous system neoplasm	0.000124	0.0356	CbGeAlD
Valproic Acid—PTGS1—ganglion—peripheral nervous system neoplasm	0.000118	0.0338	CbGeAlD
Valproic Acid—ACADSB—cerebellum—peripheral nervous system neoplasm	0.000112	0.0321	CbGeAlD
Valproic Acid—ALDH5A1—cerebellum—peripheral nervous system neoplasm	9.85e-05	0.0282	CbGeAlD
Valproic Acid—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	9.77e-05	0.028	CbGeAlD
Valproic Acid—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.38e-05	0.000317	CcSEcCtD
Valproic Acid—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000316	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000315	CcSEcCtD
Valproic Acid—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.31e-05	0.000315	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.3e-05	0.000314	CcSEcCtD
Valproic Acid—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000314	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000313	CcSEcCtD
Valproic Acid—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000312	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.23e-05	0.000312	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—peripheral nervous system neoplasm	9.2e-05	0.000311	CcSEcCtD
Valproic Acid—Asthenia—Vincristine—peripheral nervous system neoplasm	9.17e-05	0.00031	CcSEcCtD
Valproic Acid—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000309	CcSEcCtD
Valproic Acid—Drowsiness—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000307	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.09e-05	0.000307	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000307	CcSEcCtD
Valproic Acid—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.07e-05	0.000306	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.02e-05	0.000305	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—peripheral nervous system neoplasm	9.02e-05	0.000305	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9e-05	0.000304	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000303	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.94e-05	0.000302	CcSEcCtD
Valproic Acid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.93e-05	0.000302	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—peripheral nervous system neoplasm	8.92e-05	0.000301	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.0003	CcSEcCtD
Valproic Acid—Constipation—Etoposide—peripheral nervous system neoplasm	8.85e-05	0.000299	CcSEcCtD
Valproic Acid—Pain—Etoposide—peripheral nervous system neoplasm	8.85e-05	0.000299	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000299	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000299	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000298	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000298	CcSEcCtD
Valproic Acid—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.77e-05	0.000296	CcSEcCtD
Valproic Acid—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.74e-05	0.000295	CcSEcCtD
Valproic Acid—Sweating—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.000295	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000295	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000291	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000291	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.00029	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.00029	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000289	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000288	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.53e-05	0.000288	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.5e-05	0.000287	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000287	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000286	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.000286	CcSEcCtD
Valproic Acid—Dizziness—Vincristine—peripheral nervous system neoplasm	8.45e-05	0.000285	CcSEcCtD
Valproic Acid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.43e-05	0.000285	CcSEcCtD
Valproic Acid—ABAT—cerebellum—peripheral nervous system neoplasm	8.43e-05	0.0242	CbGeAlD
Valproic Acid—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000284	CcSEcCtD
Valproic Acid—Rash—Alitretinoin—peripheral nervous system neoplasm	8.36e-05	0.000282	CcSEcCtD
Valproic Acid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.35e-05	0.000282	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000282	CcSEcCtD
Valproic Acid—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.33e-05	0.000281	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000281	CcSEcCtD
Valproic Acid—Headache—Alitretinoin—peripheral nervous system neoplasm	8.31e-05	0.000281	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.000278	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000277	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000277	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000277	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.000276	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.000276	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000276	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000276	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000276	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000274	CcSEcCtD
Valproic Acid—Vomiting—Vincristine—peripheral nervous system neoplasm	8.13e-05	0.000274	CcSEcCtD
Valproic Acid—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.11e-05	0.000274	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000274	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000273	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000272	CcSEcCtD
Valproic Acid—Rash—Vincristine—peripheral nervous system neoplasm	8.06e-05	0.000272	CcSEcCtD
Valproic Acid—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.05e-05	0.000272	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000272	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000271	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.00027	CcSEcCtD
Valproic Acid—Headache—Vincristine—peripheral nervous system neoplasm	8.01e-05	0.00027	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.000269	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000268	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000267	CcSEcCtD
Valproic Acid—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.88e-05	0.000266	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000266	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000265	CcSEcCtD
Valproic Acid—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.73e-05	0.000261	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000261	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.00026	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000258	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.63e-05	0.000258	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000257	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000257	CcSEcCtD
Valproic Acid—Nausea—Vincristine—peripheral nervous system neoplasm	7.59e-05	0.000256	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000256	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000255	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000254	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000253	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000252	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000251	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—peripheral nervous system neoplasm	7.43e-05	0.000251	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000251	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.00025	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.00025	CcSEcCtD
Valproic Acid—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	7.38e-05	0.0212	CbGeAlD
Valproic Acid—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000249	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000249	CcSEcCtD
Valproic Acid—Chills—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000248	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—peripheral nervous system neoplasm	7.32e-05	0.000247	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000246	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000246	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000244	CcSEcCtD
Valproic Acid—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.18e-05	0.000243	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000242	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000241	CcSEcCtD
Valproic Acid—Rash—Cisplatin—peripheral nervous system neoplasm	7.12e-05	0.000241	CcSEcCtD
Valproic Acid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.12e-05	0.00024	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.00024	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.08e-05	0.000239	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000239	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000238	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.01e-05	0.000237	CcSEcCtD
Valproic Acid—Tension—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000236	CcSEcCtD
Valproic Acid—SLC22A5—parotid gland—peripheral nervous system neoplasm	6.97e-05	0.02	CbGeAlD
Valproic Acid—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000235	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000233	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000232	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000232	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—peripheral nervous system neoplasm	6.85e-05	0.000231	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000231	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000231	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.00023	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000229	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000228	CcSEcCtD
Valproic Acid—Nausea—Cisplatin—peripheral nervous system neoplasm	6.71e-05	0.000227	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000226	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000226	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000224	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000223	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—peripheral nervous system neoplasm	6.58e-05	0.000222	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000222	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000222	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000221	CcSEcCtD
Valproic Acid—Rash—Etoposide—peripheral nervous system neoplasm	6.53e-05	0.00022	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.52e-05	0.00022	CcSEcCtD
Valproic Acid—Headache—Etoposide—peripheral nervous system neoplasm	6.49e-05	0.000219	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000219	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000218	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000218	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000217	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000216	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000216	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000215	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000215	CcSEcCtD
Valproic Acid—HDAC2—cerebellum—peripheral nervous system neoplasm	6.35e-05	0.0182	CbGeAlD
Valproic Acid—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000214	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000212	CcSEcCtD
Valproic Acid—Cough—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.00021	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000209	CcSEcCtD
Valproic Acid—Nausea—Etoposide—peripheral nervous system neoplasm	6.15e-05	0.000208	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000207	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000206	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000205	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000204	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000204	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000204	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000204	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000204	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000203	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000202	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.0002	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.0002	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.0002	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000199	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000198	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000196	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000196	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000196	CcSEcCtD
Valproic Acid—Infection—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000195	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000194	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000192	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000192	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000192	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000191	CcSEcCtD
Valproic Acid—SLC16A1—cerebellum—peripheral nervous system neoplasm	5.64e-05	0.0162	CbGeAlD
Valproic Acid—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.00019	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.000189	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000189	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000189	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000189	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000189	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000188	CcSEcCtD
Valproic Acid—CYP2A6—cerebellum—peripheral nervous system neoplasm	5.56e-05	0.0159	CbGeAlD
Valproic Acid—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000187	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000187	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000185	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000183	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000183	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000181	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000181	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.00018	CcSEcCtD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—peripheral nervous system neoplasm	5.29e-05	0.000891	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000179	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000178	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000178	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000177	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000177	CcSEcCtD
Valproic Acid—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.24e-05	0.000882	CbGpPWpGaD
Valproic Acid—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000176	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000176	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000175	CcSEcCtD
Valproic Acid—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	5.18e-05	0.000872	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.17e-05	0.000871	CbGpPWpGaD
Valproic Acid—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000175	CcSEcCtD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—peripheral nervous system neoplasm	5.17e-05	0.000871	CbGpPWpGaD
Valproic Acid—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000174	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000173	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—GNAS—peripheral nervous system neoplasm	5.11e-05	0.000861	CbGpPWpGaD
Valproic Acid—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000173	CcSEcCtD
Valproic Acid—CYP2C18—Metabolism—NME1—peripheral nervous system neoplasm	5.1e-05	0.000859	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.07e-05	0.000854	CbGpPWpGaD
Valproic Acid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.00017	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000169	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	5.02e-05	0.000845	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.01e-05	0.000844	CbGpPWpGaD
Valproic Acid—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000169	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000169	CcSEcCtD
Valproic Acid—HDAC2—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.99e-05	0.000841	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PPP3R1—peripheral nervous system neoplasm	4.99e-05	0.00084	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.97e-05	0.000838	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.96e-05	0.000836	CbGpPWpGaD
Valproic Acid—Pain—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000168	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000168	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.93e-05	0.00083	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—COX2—peripheral nervous system neoplasm	4.91e-05	0.000827	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000165	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—BCHE—peripheral nervous system neoplasm	4.86e-05	0.000818	CbGpPWpGaD
Valproic Acid—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000164	CcSEcCtD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.84e-05	0.000814	CbGpPWpGaD
Valproic Acid—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000163	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000162	CcSEcCtD
Valproic Acid—HDAC2—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.79e-05	0.000806	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.78e-05	0.000806	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000162	CcSEcCtD
Valproic Acid—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	4.78e-05	0.000805	CbGpPWpGaD
Valproic Acid—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000161	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.00016	CcSEcCtD
Valproic Acid—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.74e-05	0.000799	CbGpPWpGaD
Valproic Acid—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.00016	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.71e-05	0.000793	CbGpPWpGaD
Valproic Acid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000158	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000157	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.63e-05	0.00078	CbGpPWpGaD
Valproic Acid—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000156	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.62e-05	0.000778	CbGpPWpGaD
Valproic Acid—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000156	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000155	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000155	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000155	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000155	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—TH—peripheral nervous system neoplasm	4.57e-05	0.000769	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—CASP3—peripheral nervous system neoplasm	4.55e-05	0.000767	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.54e-05	0.000764	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.52e-05	0.000762	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTPN11—peripheral nervous system neoplasm	4.49e-05	0.000756	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.49e-05	0.000755	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GNAS—peripheral nervous system neoplasm	4.47e-05	0.000752	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.44e-05	0.000747	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000149	CcSEcCtD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.42e-05	0.000744	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.4e-05	0.000741	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000148	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-05	0.000738	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—peripheral nervous system neoplasm	4.32e-05	0.000728	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000144	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000144	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.26e-05	0.000717	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	4.25e-05	0.000716	CbGpPWpGaD
Valproic Acid—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000143	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000143	CcSEcCtD
Valproic Acid—UGT1A9—Metabolism—GNS—peripheral nervous system neoplasm	4.21e-05	0.000709	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.18e-05	0.000704	CbGpPWpGaD
Valproic Acid—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000141	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000139	CcSEcCtD
Valproic Acid—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.05e-05	0.000682	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NME1—peripheral nervous system neoplasm	4.03e-05	0.000679	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.02e-05	0.000677	CbGpPWpGaD
Valproic Acid—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000134	CcSEcCtD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	3.96e-05	0.000666	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000134	CcSEcCtD
Valproic Acid—SLC16A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.96e-05	0.000666	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.94e-05	0.000664	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—COX2—peripheral nervous system neoplasm	3.88e-05	0.000654	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	3.87e-05	0.000652	CbGpPWpGaD
Valproic Acid—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.00013	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.00013	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—NRAS—peripheral nervous system neoplasm	3.82e-05	0.000643	CbGpPWpGaD
Valproic Acid—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000128	CcSEcCtD
Valproic Acid—HDAC2—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.78e-05	0.000637	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.75e-05	0.000632	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GNAS—peripheral nervous system neoplasm	3.73e-05	0.000628	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.69e-05	0.000622	CbGpPWpGaD
Valproic Acid—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000125	CcSEcCtD
Valproic Acid—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	3.69e-05	0.000621	CbGpPWpGaD
Valproic Acid—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000124	CcSEcCtD
Valproic Acid—Rash—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000124	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.66e-05	0.000616	CbGpPWpGaD
Valproic Acid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000123	CcSEcCtD
Valproic Acid—Headache—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000123	CcSEcCtD
Valproic Acid—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.62e-05	0.00061	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.58e-05	0.000602	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.55e-05	0.000599	CbGpPWpGaD
Valproic Acid—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.00012	CcSEcCtD
Valproic Acid—HDAC9—Disease—ERBB2—peripheral nervous system neoplasm	3.55e-05	0.000598	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.54e-05	0.000596	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—TH—peripheral nervous system neoplasm	3.53e-05	0.000594	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.49e-05	0.000588	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.49e-05	0.000588	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SLC2A1—peripheral nervous system neoplasm	3.48e-05	0.000586	CbGpPWpGaD
Valproic Acid—Nausea—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000116	CcSEcCtD
Valproic Acid—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	3.43e-05	0.000578	CbGpPWpGaD
Valproic Acid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000115	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000114	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000114	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000114	CcSEcCtD
Valproic Acid—SLC16A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.34e-05	0.000563	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	3.29e-05	0.000554	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	3.24e-05	0.000546	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—peripheral nervous system neoplasm	3.22e-05	0.000543	CbGpPWpGaD
Valproic Acid—SLC22A5—cerebellum—peripheral nervous system neoplasm	3.22e-05	0.00924	CbGeAlD
Valproic Acid—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000108	CcSEcCtD
Valproic Acid—SLC16A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.19e-05	0.000537	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	3.16e-05	0.000533	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.15e-05	0.000531	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.14e-05	0.00053	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—TH—peripheral nervous system neoplasm	3.14e-05	0.000529	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	3.14e-05	0.000528	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	3.12e-05	0.000525	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	3.11e-05	0.000524	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	3.11e-05	0.000523	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.06e-05	0.000516	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	2.99e-05	0.000504	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.97e-05	0.000501	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	2.93e-05	0.000494	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.88e-05	0.000485	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.82e-05	0.000476	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—peripheral nervous system neoplasm	2.79e-05	0.00047	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.73e-05	0.000461	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	2.72e-05	0.000459	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—peripheral nervous system neoplasm	2.7e-05	0.000455	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.65e-05	0.000446	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—peripheral nervous system neoplasm	2.64e-05	0.000445	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AKT1—peripheral nervous system neoplasm	2.63e-05	0.000442	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.62e-05	0.000442	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.62e-05	0.000441	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.6e-05	0.000438	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.57e-05	0.000432	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	2.56e-05	0.000431	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.56e-05	0.000431	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	2.55e-05	0.000429	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.55e-05	0.000429	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.53e-05	0.000426	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.52e-05	0.000424	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—peripheral nervous system neoplasm	2.51e-05	0.000424	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.51e-05	0.000423	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.49e-05	0.00042	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.49e-05	0.00042	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.48e-05	0.000419	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	2.47e-05	0.000415	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.45e-05	0.000413	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.43e-05	0.00041	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—peripheral nervous system neoplasm	2.42e-05	0.000407	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.41e-05	0.000407	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	2.39e-05	0.000403	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.36e-05	0.000398	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.35e-05	0.000395	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.27e-05	0.000383	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.26e-05	0.00038	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.24e-05	0.000378	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—peripheral nervous system neoplasm	2.23e-05	0.000376	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.22e-05	0.000373	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	2.15e-05	0.000363	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.14e-05	0.00036	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.13e-05	0.000359	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	2.12e-05	0.000358	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	2.09e-05	0.000352	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	2.08e-05	0.00035	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.07e-05	0.000349	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.05e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	2.05e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	2.04e-05	0.000344	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	2.03e-05	0.000343	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	2.02e-05	0.000341	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—peripheral nervous system neoplasm	2.02e-05	0.000341	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	2e-05	0.000336	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.98e-05	0.000333	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—peripheral nervous system neoplasm	1.97e-05	0.000333	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-05	0.000331	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.96e-05	0.00033	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTPN11—peripheral nervous system neoplasm	1.95e-05	0.000328	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.93e-05	0.000326	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.9e-05	0.000319	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.89e-05	0.000318	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—peripheral nervous system neoplasm	1.85e-05	0.000312	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.82e-05	0.000307	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.8e-05	0.000304	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.77e-05	0.000298	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.77e-05	0.000298	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.76e-05	0.000297	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.76e-05	0.000296	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—peripheral nervous system neoplasm	1.74e-05	0.000294	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.000291	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000288	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.67e-05	0.000282	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.66e-05	0.00028	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.00028	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000278	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.65e-05	0.000278	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.64e-05	0.000277	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.62e-05	0.000273	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.000267	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000267	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—peripheral nervous system neoplasm	1.56e-05	0.000263	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000263	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.55e-05	0.000261	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.54e-05	0.000259	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—peripheral nervous system neoplasm	1.54e-05	0.000259	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.48e-05	0.000249	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.45e-05	0.000244	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.42e-05	0.000239	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.38e-05	0.000233	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000232	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.00023	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000227	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000226	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.34e-05	0.000226	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.32e-05	0.000223	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.31e-05	0.000221	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.000215	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000215	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.26e-05	0.000212	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000211	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.25e-05	0.00021	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.23e-05	0.000207	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000206	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000203	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.000202	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.19e-05	0.0002	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—peripheral nervous system neoplasm	1.17e-05	0.000198	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000197	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.14e-05	0.000192	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-05	0.000191	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.1e-05	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.000184	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—peripheral nervous system neoplasm	1.09e-05	0.000184	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000182	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000181	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.07e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000173	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	0.00017	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00017	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	9.86e-06	0.000166	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.78e-06	0.000165	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.66e-06	0.000163	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	9.52e-06	0.00016	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.33e-06	0.000157	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	9.23e-06	0.000155	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.8e-06	0.000148	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	8.7e-06	0.000147	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	8.68e-06	0.000146	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—peripheral nervous system neoplasm	8.56e-06	0.000144	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	8.54e-06	0.000144	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.2e-06	0.000138	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—peripheral nervous system neoplasm	8.14e-06	0.000137	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	7.89e-06	0.000133	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	7.77e-06	0.000131	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.77e-06	0.000131	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.64e-06	0.000129	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	7.62e-06	0.000128	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—peripheral nervous system neoplasm	7.56e-06	0.000127	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.52e-06	0.000127	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	7.41e-06	0.000125	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.2e-06	0.000121	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	7.08e-06	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.95e-06	0.000117	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.92e-06	0.000117	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	6.46e-06	0.000109	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.27e-06	0.000106	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.09e-06	0.000103	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.05e-06	0.000102	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6e-06	0.000101	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.94e-06	0.0001	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.81e-06	9.78e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.72e-06	9.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	5.64e-06	9.51e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	5.49e-06	9.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.29e-06	8.92e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.67e-06	7.87e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.58e-06	7.72e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	4.46e-06	7.51e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	3.64e-06	6.13e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.44e-06	5.79e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.77e-06	4.67e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.71e-06	4.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.35e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.1e-06	3.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.91e-06	3.22e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.63e-06	2.75e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.26e-06	2.12e-05	CbGpPWpGaD
